NASDAQ
Apogee Therapeutics, Inc. (APGE) has a current ratio of 26.57x as of Monday, May 25, 2026. This represents a 49.91% increase compared to its 12-month average of 17.72x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.